Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.
about
The role of osteoprotegerin in arthritisA model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKLPotassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal diseaseRANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapiesPromising bone-related therapeutic targets for rheumatoid arthritis.Influence of antiTNF-alpha antibody treatment on fracture healing under chronic inflammation.Bone damage in rheumatoid arthritis: mechanistic insights and approaches to preventionRodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy.Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation.Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis.Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort.RANK, RANKL and osteoprotegerin in arthritic bone loss.Hand bone densitometry: a more sensitive standard for the assessment of early bone damage in rheumatoid arthritis.IKK{beta} as a target for treatment of inflammation induced bone loss.Rheumatic diseases: the effects of inflammation on bone.CD44 is a determinant of inflammatory bone loss.Mechanisms of Disease: the link between RANKL and arthritic bone disease.RANK ligand inhibition with denosumab for the management of osteoporosis.Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.Genetic confirmation for a central role for TNFα in the direct action of thyroid stimulating hormone on the skeletonLocal delivery of osteoprotegerin inhibits mechanically mediated bone modeling in orthodontic tooth movementLymphocyte-derived cytokines in inflammatory arthritis.Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis.The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis.Denosumab: an investigational drug for the management of postmenopausal osteoporosisInflammation, cancer, and bone loss.Conjugated linoleic Acid prevents ovariectomy-induced bone loss in mice by modulating both osteoclastogenesis and osteoblastogenesis.Osteoporosis in inflammatory joint diseases.Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis.Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future.Skeletal and extraskeletal actions of denosumab.Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo.Can bone loss in rheumatoid arthritis be prevented?Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.Inflammatory bone loss in experimental periodontitis induced by Aggregatibacter actinomycetemcomitans in interleukin-1 receptor antagonist knockout mice.Physiological and pathophysiological bone turnover - role of the immune system.Identification of small molecule inhibitors of RANKL and TNF signalling as anti-inflammatory and antiresorptive agents in mice.Cytokine and hormonal regulation of bone marrow immune cell Wnt10b expression.Suppressive Effect of the n-Hexane Extract of Litsea japonica Fruit Flesh on Monosodium-Iodoacetate-Induced Osteoarthritis in Rats.
P2860
Q24797889-9E60E166-BC61-4466-B911-E1CE31D9A389Q24799036-319FE67C-CEEE-4C50-9F26-E63E8B92B7D5Q28252713-029CC504-25ED-4D3A-83B4-A0815064ADB9Q28570898-206E3A94-4266-45D4-B696-56660FC9C486Q33554023-2FF6CFB8-69B3-4CAD-B476-C9D296944C56Q33761069-7BBC306E-15FA-4D22-BF44-8E255DF85038Q34001621-FE38B2CD-4D75-4086-8AE9-E9BC55D4F8E5Q34497135-22D99FEB-1728-4FD6-AC92-01154A627721Q35075554-47B64BC1-292C-4B1F-BF40-6AEE985ED3B2Q35083436-0FB21EA3-6031-4F54-902E-5F31EBA6235EQ35643989-31630F5D-4F85-4847-B369-0DA5928BFCB9Q35899487-8AE315A3-CBEC-4D34-A965-EA0314BC6A49Q36078073-A93794D4-945F-44FF-AD09-98F85239A793Q36204174-76D2F91C-56EA-451C-8AE2-E7DE63654528Q36292663-0C2FBC1F-E5FE-48D0-978C-1B69E0B03FF8Q36324975-C1F5F852-B669-40FC-9A75-1762100AE3CEQ36403383-960EC6D1-2A04-4464-ABB0-45A35643C582Q36577375-5920DDF1-5455-41AA-B34B-26579A4E9FFAQ36600255-0AF3DE0E-9693-4CF5-8964-548291816ED1Q36860987-2CD42251-41FE-427C-BD8E-DDBE67DFB4FDQ36932168-D69069F8-9F78-4E71-8FB3-A02982579ED6Q36968961-72DF921A-5362-400F-88D2-44AA0B89456CQ37118786-97079599-B2A2-4624-9FC8-F0AC5D45C968Q37206612-01B2324C-0446-48F5-9722-6084B71AE784Q37287589-5F44D0AB-A135-4992-BDD4-1AB6697FC5ABQ37307805-EBAFF566-34D7-49B3-98D4-302951F8FE3BQ37316183-5A36A291-8EC9-4BBF-A368-CB9D98D02053Q37627024-39605FF1-26E9-4EC8-A96F-549A76A278CEQ37765505-3DDA23DF-D25F-4447-AF27-1BB5D8D669B7Q37801555-19408787-E89B-4B7A-BD81-326B43364642Q37882064-6DBA5A19-CF48-4029-AD80-AA48FDD488CAQ38009712-2F8246E0-2A5C-4FCD-AC84-9888C9CFFC25Q38114066-11996B66-E2B8-4F3E-B43D-6CF04925F5DCQ38115190-C2560C7C-9CDA-4CBE-A6D6-C08FA8678838Q38593977-693AA56E-C1F1-4424-B4B9-CF218EE5C570Q38852509-B11E6026-DBA6-43ED-9414-C0FFB21F93C0Q38867785-029A456B-3D5C-49E7-B33B-1DE9ECB6BBC8Q39085876-F189C850-B5B2-47CD-A8F6-77931FDD4127Q41363594-8DDB02F5-71D2-4A89-827A-0E7B9636F096Q41623255-2249162E-94BB-4973-9DDF-81EB821CC38B
P2860
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Osteoprotegerin protects again ...... crosis factor-transgenic mice.
@en
Osteoprotegerin protects again ...... crosis factor-transgenic mice.
@nl
type
label
Osteoprotegerin protects again ...... crosis factor-transgenic mice.
@en
Osteoprotegerin protects again ...... crosis factor-transgenic mice.
@nl
prefLabel
Osteoprotegerin protects again ...... crosis factor-transgenic mice.
@en
Osteoprotegerin protects again ...... crosis factor-transgenic mice.
@nl
P2093
P2860
P50
P356
P1476
Osteoprotegerin protects again ...... crosis factor-transgenic mice.
@en
P2093
Andreas Schulz
Birgit Görtz
Brad Bolon
Helga Bergmeister
Jochen Zwerina
Kurt Redlich
Silvia Hayer
P2860
P304
P356
10.1002/ART.11150
P577
2003-07-01T00:00:00Z